2
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Leukemia, Myeloid, Acute
5
Lymphoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Spondylolisthesis
1
Spinal Stenosis
1
Spinal Cord Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Intervertebral Disc Displacement
1
Intervertebral Disc Degeneration
1
Hemoglobinuria, Paroxysmal
1
Interventions
Transplantation, Homologous
1
Transplantation, Autologous
1
Saline Solution
1
Clonidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Spondylolisthesis
×
Transplantation, Homologous
×
Clear all
NCT00974623
2017-04-05
APPROACH-001
Baxter Healthcare Corporation
Terminated
329 enrolled